Super Refractory Status Epilepticus in Paraneoplastic Autoimmune Encephalitis Associated With Ovarian Teratoma: A Fatal Case Report
Keywords:
Anti-N-Methyl-D-Aspartate Receptor Encephalitis, Teratoma, Ovarian, Status Epilepticus, Case ReportAbstract
Background: Autoimmune Encephalitis(AIE) is a group of inflammatory central nervous system(CNS) disorders occurring due to breakdown of immune tolerance against specific CNS antigens. AIE can be idiopathic or can precipitate post-viral infection or as a paraneoplastic complication. Ovarian teratoma is consistently linked with production of immunoglobulin G(IgG) against N-Methyl-D-Aspartate receptors(NMDAR) found on neuronal membranes in the hippocampus and forebrain. The incidence of anti-NMDAR encephalitis is 1.5/million/year. The symptoms may initially mimic a viral prodrome or psychiatric illness. Frank neurological symptoms like seizures, movement disorders, catatonia, memory loss, and impaired cognition occur later. Diagnostic modalities include electroencephalogram(EEG), neuroimaging, and serology and/or cerebrospinal fluid(CSF) analysis for autoantibody detection, followed by computed tomography(CT) of the chest, abdomen, and pelvis for detection of lung, breast, ovarian, testicular, or other abdominal tumors. The condition responds well to tumor removal, plasmapheresis, steroids, intravenous immunoglobulin(IVIG), and other immunotherapeutic agents such as Cyclophosphamide. Anti-NMDAR encephalitis can be complexed by super refractory status epilepticus(SRSE) which is a state of neurological urgency and is accompanied by profound mortality. SRSE refers to seizures that persist for 24 hours or more after starting anaesthetics, including the seizures that recur after stopping the anaesthetics.
The Case: A 39-year-old, previously healthy female, developed three episodes of seizures on a single day, involving involuntary movements of all four limbs with tongue bite and mild fever. She was stable for the next 11 days after which she developed irritability, behavioural abnormalities, and reduced responsiveness. She was brought to a local hospital in an unconscious state. Glasgow coma scale score was 9(G2V2M5). Brain magnetic resonance imaging(MRI) revealed left hippocampal swelling. EEG revealed no significant abnormality. CSF analysis revealed elevated protein and cell count, normal glucose, and negative microscopy for organisms. The patient had a seizure during hospitalisation at the local hospital, for which phenytoin was given. The patient and family decided to continue further management at our hospital. Virological analysis was normal. CSF autoimmune encephalitis panel revealed the presence of anti-NMDA antibodies. A contrast-enhanced CT of the abdomen and pelvis was done which revealed an approximately 37 x 37 x 35 mm-sized right ovarian dermoid cyst(Figure 1). The patient was started on Methylprednisolone, IVIG, and Cyclophosphamide. Antiepileptics Levetiracetam, Valproate, and Phenytoin were ineffective in achieving seizure control. Midazolam, Ketamine, and Propofol were used to sedate the patient. The patient was intubated and provided with oxygen therapy. The patient had persistent seizures for 24 hours despite the anesthetic therapy, leading to the diagnosis of SRSE. Unfortunately, despite aggressive management, the patient died due to cardiorespiratory arrest, before tumor resection surgery could be performed.
Conclusion: The case underlines the importance of maintaining high clinical suspicion for paraneoplastic autoimmune encephalitis in female patients with psychiatric presentations followed by SRSE. Early diagnosis is imperative because immunotherapy and surgical tumor removal dramatically improve clinical outcomes. As seen in this case, delayed tumor management contributes to rapid disease progression and profound mortality rates.
References
None
Downloads
Published
How to Cite
Issue
Section
Categories
License
Copyright (c) 2026 Yashasvi Sanghvi, Srujana Rao

This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors who publish with this journal agree to the following terms:
- The Author retains copyright in the Work, where the term “Work” shall include all digital objects that may result in subsequent electronic publication or distribution.
- Upon acceptance of the Work, the author shall grant to the Publisher the right of first publication of the Work.
- The Author shall grant to the Publisher and its agents the nonexclusive perpetual right and license to publish, archive, and make accessible the Work in whole or in part in all forms of media now or hereafter known under a Creative Commons Attribution 4.0 International License or its equivalent, which, for the avoidance of doubt, allows others to copy, distribute, and transmit the Work under the following conditions:
- Attribution—other users must attribute the Work in the manner specified by the author as indicated on the journal Web site; with the understanding that the above condition can be waived with permission from the Author and that where the Work or any of its elements is in the public domain under applicable law, that status is in no way affected by the license.
- The Author is able to enter into separate, additional contractual arrangements for the nonexclusive distribution of the journal's published version of the Work (e.g., post it to an institutional repository or publish it in a book), as long as there is provided in the document an acknowledgment of its initial publication in this journal.
- Authors are permitted and encouraged to post online a prepublication manuscript (but not the Publisher’s final formatted PDF version of the Work) in institutional repositories or on their Websites prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work. Any such posting made before acceptance and publication of the Work shall be updated upon publication to include a reference to the Publisher-assigned DOI (Digital Object Identifier) and a link to the online abstract for the final published Work in the Journal.
- Upon Publisher’s request, the Author agrees to furnish promptly to Publisher, at the Author’s own expense, written evidence of the permissions, licenses, and consents for use of third-party material included within the Work, except as determined by Publisher to be covered by the principles of Fair Use.
- The Author represents and warrants that:
- the Work is the Author’s original work;
- the Author has not transferred, and will not transfer, exclusive rights in the Work to any third party;
- the Work is not pending review or under consideration by another publisher;
- the Work has not previously been published;
- the Work contains no misrepresentation or infringement of the Work or property of other authors or third parties; and
- the Work contains no libel, invasion of privacy, or other unlawful matter.
- The Author agrees to indemnify and hold Publisher harmless from the Author’s breach of the representations and warranties contained in Paragraph 6 above, as well as any claim or proceeding relating to Publisher’s use and publication of any content contained in the Work, including third-party content.
Enforcement of copyright
The IJMS takes the protection of copyright very seriously.
If the IJMS discovers that you have used its copyright materials in contravention of the license above, the IJMS may bring legal proceedings against you seeking reparation and an injunction to stop you using those materials. You could also be ordered to pay legal costs.
If you become aware of any use of the IJMS' copyright materials that contravenes or may contravene the license above, please report this by email to contact@ijms.org
Infringing material
If you become aware of any material on the website that you believe infringes your or any other person's copyright, please report this by email to contact@ijms.org



